Exscientia

Exscientia is a clinical-stage pharmatech company that combines AI-driven drug design with precision medicine to accelerate the development of more effective therapies. The company's platform uses active learning algorithms and generative chemistry to design novel drug molecules optimized for potency, selectivity, and pharmacokinetic properties, reducing typical design timelines from years to months. Exscientia was the first company to place an AI-designed drug molecule into clinical trials a...

Threads